Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Arteriosclerosis, Thrombosis, and Vascular Biology. 1984;4:403-406

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buchanan, M. R.
Right arrow Articles by Hirsh, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buchanan, M. R.
Right arrow Articles by Hirsh, J.

Arteriosclerosis, Vol 4, 403-406, Copyright © 1984 by American Heart Association

ARTICLES

Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits

MR Buchanan and J Hirsh

We performed studies to examine the mechanism responsible for the antithrombogenic effect of aspirin in experimental animals. We measured the effect of 10 and 100 mg/kg doses of aspirin, salicylate, or a combination of both on the accumulation of radiolabeled platelets onto injured carotid arteries in rabbits. The effects of these agents on thrombogenicity measured as platelet accumulation onto injured carotid arteries, were correlated with the ability to inhibit platelet thromboxane A2 and vessel wall prostacyclin synthesis. We found that a low dose of aspirin significantly inhibited platelet accumulation onto the injured vessels, while a high dose reversed this effect. Thromboxane A2 and prostacyclin production, however, were maximally inhibited in rabbits given either aspirin dose. The reversal of the antithrombotic effect of the low dose of aspirin by a high dose of aspirin was simulated by administering a combination dose of high-dose salicylate and low-dose aspirin. We concluded that the reversal of the antithrombotic effect of a 10 mg/kg dose of aspirin by a higher dose of aspirin could not be explained solely by the inhibition of PGI2 synthesis and was affected by the salicylate moiety of aspirin.


This article has been cited by other articles:


Home page
 StrokeHome page
G. R. Thomas, H. Thibodeaux, C. J. Errett, M. M. Bednar, C. E. Gross, and W. F. Bennett
Intravenous Aspirin Causes a Paradoxical Attenuation of Cerebrovascular Thrombolysis
Stroke, June 1, 1995; 26(6): 1039 - 1046.
[Abstract] [Full Text]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1984 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.